Clinical Trial Update: TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN) [Phase 3]

View source ↗

Summary

Phase 3 trial TC-015-IN compares TachoComb S to standard surgical treatment for surgical resection of superficial renal tumours; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• TachoComb S

Snippet

Sponsor: Takeda | Conditions: Surgical Resection of Superficial Renal Tumour | Phase 3 | Status: COMPLETED